Please assess the completion status of the following clinical trial:

Trial Title: The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* children with a diagnosis of chronic lung disease (CLD) secondary to bronchopulmonary dysplasia (BPD) as defined by ATS.~* children who receive primary care at High Risk Infant Clinic or High Risk Children's Clinic~Exclusion Criteria:~* Children with Cystic Fibrosis or bronchiectasis~* Children with cardiac arrhythmias~* Children with cyanotic heart disease~* Children with colitis~* Children with a known Macrolide allergy~* Children taking medications known to interact with macrolides~* Children with short bowel syndrome~* Children with kidney or liver failure

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 6 Years
- Healthy Volunteers: f

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): The control group will be provided with a placebo medication of similar taste, color, texture, and consistency as the study medication, and will be dispensed once a day on Monday, Wednesday, and Friday.
- azithromycin (Type: EXPERIMENTAL): Patients will receive azithromycin at a dose of 5 mg/kg to be given once a day on Monday, Wednesday, and Friday. The dosage will be not be adjusted if a new weight is obtained during the trial period.

Based on this trial design, predict the completion outcome and termination type (if applicable).